- Global Pharma News & Resources

Global Proteinase K Market Size to touch US$ 87 Million by 2025 at a CAGR of 7.2%

Noida, Uttar Pradesh, India, February 22 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Global Proteinase K Market is estimated to see healthy growth, pegged at a CAGR of ~7.2% during the forecast period 2020-2025. The global proteinase K market has witnessed positive growth due to rising research & development (R&D) activities and increasing related investments by research institutes and pharmaceutical companies in innovation. Growing usage in different applications such as mitochondria isolation and nucleic acid will positively boost the proteinase K market. The presence of local and multinational players with a wide variety of product offering will help bolster the proteinase K market over the forecast period. The vast growth in the use of proteinase K in disease diagnosis and drug discovery is expected to positively impact the market’s growth during the forecast period. However, the purity issues, as well as the presence of other nucleases and proteins in the proteinase K, may hinder its growth in the future.

Request Sample Report at:

The rising adoption of proteinase K in the R&D of rare diseases is one of the significant factors that are predictable to offer lucrative growth opportunities for manufacturers present in the market. For instance, in April 2019, Scripps Research researchers reported that labeling light chains with fluorophores and coupling shape changes to cleavage by proteinase K to identify a small molecules group that avoid structural changes to proteins that cause AL amyloidosis, a rare and progressive disease. However, proteinase K’s low thermal stability limits the hydrolysis and aminolysis reactions in industrial processes, which is restricts the market’s growth during the forecast period.

Although, the international market is witnessing the rising proteinase K applications in DNA extraction from food samples to test the presence of genetically modified organisms. One such application involves homogenization of frozen northern shrimps in 200 µl of water and blending the homogenates with Lysis Solution CBV and Proteinase K. Thus, the growing proteinase K usage will drive the market growth.

Major manufactuers operating in the market focus on partnerships to expand their product portfolio and strengthen their position in the global market. For instance, in July 2018, Norgen Biotek Corp. allied with Diversigen Inc. to provide a combined offering from sample collection, ambient temperature stabilization for transport and logistics for all types of microbiome samples and formats, and the purification of high quality, inhibitor-free nucleic acids from these samples.

Merck KGaA, Codexis, Inc., F. Hoffmann-La Roche Ltd., Amano Enzyme Inc., Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Amicogen, Dyadic International, BBI Solutions, Affymetrix, and American Laboratories, among others, are some crucial players included in the research study of the global proteinase K market. Such players are estimated to focused on product development as the strategic expansion in the coming years.


By Form (Lyophilized Powder Form, Liquid Form)

By Application (Purification of DNA & RNA, In Situ Hybridization, Mitochondria Isolation, Enzyme Removal)

By End-User (Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories)

By Region (Americas North America The U.S. Canada Mexico South America Brazil Rest of South America Europe Germany The U.K. France Rest of Europe Asia Pacific Japan China India Rest of Asia Pacific Middle East & Africa)

For Purchase Enquiry:

This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 22-Feb-2021